| Literature DB >> 30101294 |
Peter J H Jones1,2, Maryam Shamloo2,3, Dylan S MacKay3, Todd C Rideout4, Semone B Myrie1,2, Jogchum Plat5, Jean-Baptiste Roullet6, David J Baer7, Kara L Calkins8, Harry R Davis9, P Barton Duell10, Henry Ginsberg11, Helena Gylling12, David Jenkins13, Dieter Lütjohann14, Mohammad Moghadasian2, Robert A Moreau15, David Mymin16, Richard E Ostlund17, Rouyanne T Ras18, Javier Ochoa Reparaz19, Elke A Trautwein18, Stephen Turley20, Tim Vanmierlo21, Oliver Weingärtner22.
Abstract
Current evidence indicates that foods with added plant sterols or stanols can lower serum levels of low-density lipoprotein cholesterol. This review summarizes the recent findings and deliberations of 31 experts in the field who participated in a scientific meeting in Winnipeg, Canada, on the health effects of plant sterols and stanols. Participants discussed issues including, but not limited to, the health benefits of plant sterols and stanols beyond cholesterol lowering, the role of plant sterols and stanols as adjuncts to diet and drugs, and the challenges involved in measuring plant sterols and stanols in biological samples. Variations in interindividual responses to plant sterols and stanols, as well as the personalization of lipid-lowering therapies, were addressed. Finally, the clinical aspects and treatment of sitosterolemia were reviewed. Although plant sterols and stanols continue to offer an efficacious and convenient dietary approach to cholesterol management, long-term clinical trials investigating the endpoints of cardiovascular disease are still lacking.Entities:
Mesh:
Substances:
Year: 2018 PMID: 30101294 PMCID: PMC6130982 DOI: 10.1093/nutrit/nuy032
Source DB: PubMed Journal: Nutr Rev ISSN: 0029-6643 Impact factor: 7.110